Guidelines for Acromegaly Management: an Update

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2009 Feb 12

PMID 19208732

Citations 239

Authors

S Melmed

A Colao

A Barkan

M Molitch

A B Grossman

D Kleinberg

D Clemmons

P Chanson

E Laws

J Schlechte

M L Vance

K Ho

A Giustina

Affiliations

Soon will be listed here.

Abstract

Objective: The Acromegaly Consensus Group reconvened in November 2007 to update guidelines for acromegaly management.

Participants: The meeting participants comprised 68 pituitary specialists, including neurosurgeons and endocrinologists with extensive experience treating patients with acromegaly. EVIDENCE/CONSENSUS PROCESS: Goals of treatment and the appropriate imaging and biochemical and clinical monitoring of patients with acromegaly were enunciated, based on the available published evidence.

Conclusions: The group developed a consensus on the approach to managing acromegaly including appropriate roles for neurosurgery, medical therapy, and radiation therapy in the management of these patients.

Citing Articles

IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly.

Chiloiro S, Giampietro A, Giambo P, Costanza F, Mattogno P, Lauretti L Pituitary. 2024; 28(1):7.

PMID: 39724447 DOI: 10.1007/s11102-024-01479-9.

Acromegaly in Speckle Tracking Echocardiography-A New Cardiac Hypertrophy Phenotype? Case Report and Review.

Suchodolski A, Wojcik-Giertuga M, Kos-Kudla B, Szulik M Life (Basel). 2024; 14(11).

PMID: 39598257 PMC: 11595272. DOI: 10.3390/life14111459.

Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern.

Kim K, Kim Y, Kim S, Moon J, Kim E, Lee E Front Oncol. 2024; 14:1423606.

PMID: 39139281 PMC: 11319302. DOI: 10.3389/fonc.2024.1423606.

A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus.

Aggarwal S, Mani S, Balasubramanian A, Veluswami K, Rao S Cureus. 2024; 16(7):e64165.

PMID: 39119396 PMC: 11309083. DOI: 10.7759/cureus.64165.

Concurrent Papillary Craniopharyngioma and Growth Hormone-Secreting Pituitary Adenoma: A Rare and Aggressive Collision Tumor.

Mancini A, Mathew R, Oentoro J, Devine A, Maxwell C, Kravets I AACE Clin Case Rep. 2024; 10(4):144-148.

PMID: 39100629 PMC: 11294742. DOI: 10.1016/j.aace.2024.04.003.